Initiation of apremilast treatment decreases prescribed topical therapy amount in patients with psoriasis: a health insurance claims study in Japan
Objective Effective systemic treatments for psoriasis may reduce the need for topical therapies. The objective of this study was to evaluate changes in topical prescriptions after apremilast initiation.Materials and methods This retrospective cohort study was performed in the Japanese JMDC health in...
Saved in:
| Main Authors: | Siddharth Chaudhari, Ryuichi Ogawa, Shinichi Imafuku, Hiroshi Saruwatari, Katarzyna Jabłońska, Kathy Tran |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Journal of Dermatological Treatment |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09546634.2025.2535686 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessing the Effect of Apremilast on Serum Leptin levels in Obese Patients with Psoriasis
by: Haitham Mohammed Saad, et al.
Published: (2024-12-01) -
Successful treatment by deucravacitinib of psoriasis refractory to apremilast
by: Shigeki Inui, et al.
Published: (2025-06-01) -
Efficacy and Safety of Apremilast in Oncological Patients with Moderate-to-Severe Plaque Psoriasis: A 5 years Retrospective Observational Study
by: Lanna C, et al.
Published: (2025-05-01) -
Expression dynamics of cytokine genes is related to the apremilast treatment effectiveness in patients with severe psoriasis
by: Dmitry A. Verbenko, et al.
Published: (2024-03-01) -
Delayed lichenoid drug eruption associated with apremilast
by: Betty Hinderks-Davis, MD, et al.
Published: (2025-05-01)